BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34127009)

  • 1. Urothelial carcinoma of the graft kidney with molecular analyses: a rare case report.
    Chen JM; Kenneth Haines G; Lam W; Reddy A; Mehrotra M; Houldsworth J; Si Q
    Diagn Pathol; 2021 Jun; 16(1):53. PubMed ID: 34127009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial Carcinoma Detected by Ultrasonography in a Renal Transplant Recipient.
    Altinbas NK; Gunertem G
    Exp Clin Transplant; 2019 Apr; 17(2):259-262. PubMed ID: 30945630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived, metastatic urothelial cancer after kidney transplantation associated with a potentially oncogenic BK polyomavirus.
    Müller DC; Rämö M; Naegele K; Ribi S; Wetterauer C; Perrina V; Quagliata L; Vlajnic T; Ruiz C; Balitzki B; Grobholz R; Gosert R; Ajuh ET; Hirsch HH; Bubendorf L; Rentsch CA
    J Pathol; 2018 Mar; 244(3):265-270. PubMed ID: 29205775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: a case report.
    Oikawa M; Hatakeyama S; Fujita T; Murakami R; Hagiwara K; Narita T; Noro D; Tanaka T; Tanaka Y; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Narumi S; Ohyama C
    Transplant Proc; 2014; 46(2):616-9. PubMed ID: 24656027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypoid urothelial tumor with inverted growth pattern in the renal pelvis: morphologic and molecular characteristics of a unique diagnostic entity.
    Wobker SE; Zhong M; Epstein JI
    Hum Pathol; 2017 Jan; 59():26-33. PubMed ID: 27574810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
    Li D; Liu F; Chen Y; Li P; Liu Y; Pang Y
    Diagn Pathol; 2023 Nov; 18(1):120. PubMed ID: 37924117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial carcinoma of donor origin in a kidney transplant patient.
    Michel Ortega RM; Wolff DJ; Schandl CA; Drabkin HA
    J Immunother Cancer; 2016; 4():63. PubMed ID: 27777772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancies arising in allograft kidneys, with a first reported translocation RCC post-transplantation: A case series.
    Saleeb R; Faragalla H; Yousef GM; Stewart R; Streutker CJ
    Pathol Res Pract; 2015 Aug; 211(8):584-7. PubMed ID: 26008778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic Bilateral Nephro-Ureterectomy Approach for Complete Urinary Tract Extirpation for the Treatment of Multifocal Urothelial Carcinoma in a Kidney Transplant Patient: A Case Report and Literature Review.
    Ketsuwan C; Sangkum P; Sirisreetreerux P; Viseshsindh W; Patcharatrakul S; Kongcharoensombat W
    Transplant Proc; 2015 Sep; 47(7):2265-9. PubMed ID: 26361696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female urothelial cell carcinoma in a failed kidney graft of a male recipient.
    de Jongh HJJ; van Duijnhoven EM; Rüland A; Abdul Hamid MMA; Speel EJM; van de Beek K
    Neth J Med; 2017 Oct; 75(8):354-356. PubMed ID: 29219831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional cell carcinoma involving graft kidney in a kidney transplant recipient: a case report.
    Hong YA; Hwang HS; Sul HJ; Kim SY; Chang YK
    BMC Nephrol; 2017 Sep; 18(1):299. PubMed ID: 28934936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyomavirus large T antigen is prevalent in urothelial carcinoma post-kidney transplant.
    Yan L; Salama ME; Lanciault C; Matsumura L; Troxell ML
    Hum Pathol; 2016 Feb; 48():122-31. PubMed ID: 26615524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
    Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
    Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
    Wang CC; Huang CY; Jhuang YL; Chen CC; Jeng YM
    Histopathology; 2018 Apr; 72(5):795-803. PubMed ID: 29193225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.
    Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.
    Kim PH; Cha EK; Sfakianos JP; Iyer G; Zabor EC; Scott SN; Ostrovnaya I; Ramirez R; Sun A; Shah R; Yee AM; Reuter VE; Bajorin DF; Rosenberg JE; Schultz N; Berger MF; Al-Ahmadie HA; Solit DB; Bochner BH
    Eur Urol; 2015 Feb; 67(2):198-201. PubMed ID: 25092538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo urothelial carcinoma in a pediatric recipient of living donor kidney graft.
    Wu CY; Hung SY; Su YT; Chang HC; Yu TJ
    Pediatr Transplant; 2007 Nov; 11(7):811-3. PubMed ID: 17910664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
    Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.
    Qian CN; Furge KA; Knol J; Huang D; Chen J; Dykema KJ; Kort EJ; Massie A; Khoo SK; Vanden Beldt K; Resau JH; Anema J; Kahnoski RJ; Morreau H; Camparo P; Comperat E; Sibony M; Denoux Y; Molinie V; Vieillefond A; Eng C; Williams BO; Teh BT
    Cancer Res; 2009 Nov; 69(21):8256-64. PubMed ID: 19843858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.